- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02412046
Quantification of the Pressure Threshold Related to Tissue Injury in Bedriden Paraplegics
The aim of this study is to correlate the intensity and the duration of a mechanical strain, applied over the skin of a bedridden paraplegics, with the microvascularization parameters (oxygen saturation, blood flow and blood volume) and the early inflammatory mechanism. We want to detect the early stage of irreversible damage for each patient. To achieve this goal, we measure some specifics data over a group of 48 paraplegics admitted in the hospital for a pressure ulcer surgical treatment. The patients are randomly distributed in 4 groups. First the interface pressure between the patient body and the air mattress is recorded continuously for 3 hours (= the repositioning patient frequency): we have the pressure over each point of the patient body in contact with the mattress on this time lap. Then, we will measure the microvascularization parameters, using an O2C medical device over a trochanter on a specific anatomical area which will be thereafter biopsied. Finally, depending on the group in which they were randomly distributed, the patient will undergo a muscle biopsy on his or her trochanter at 0h, 1h, 2h or 3h after they lie down on the air mattress. This way, we will be able to determine the effect of the mechanical strain duration on the physiologic parameters. The following day, the patient is undergoing his or her surgery for removing the necrotic area of the bedsore. At the same time, we will recover some of the sample near the bedsore which would serve as a maximum inflammatory response. Then a second muscle biopsy will be performed on an innervated area to be able to determine a basal concentration of biomarkers.
The inclusion period for this study will be 3 years. All the patients are followed for 24 hours then they will be followed by medical staff in their bedsore resection setting.
The data gained for this study will hopefully help the scientific world to achieve a better understanding of the pressure ulcer aetiology. They will also be helpful to achieve a mobilization of the patient specific of his or her inherent characteristics with a high sensitivity level. This way we will have a more efficient bedsore prevention.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34295
- CHU Montpellier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Educated consent signed,
- Older than 18,
- Paraplegia for at least 6 months,
- Patient's Body Mass Index > 18,5kg/m²,
- Surgery planned for pressure ulcer resection,
- Pressure Ulcer classification (EPUAP) at least III or IV
Exclusion Criteria:
- Cardiac pathology,
- Duchenne muscular dystrophy,
- Dementia,
- Presence of a tumourous wound,
- Stade IV arteritis non-revascularisable,
- Diabetes mellitus,
- Cachexia,
- Impossibility to stop the anti-coagulant treatment 24 hours before the patient admission,
- Xylocaine allergy,
- Patient took aspirin or anti-inflammatory 3 days before the biopsy,
- Patient taking part in another study,
- Patient with no health insurance,
- Pregnant women or breast-feeding, patient unable to give his or her educated consent, ward of the state (art. L.1121-6, L.1121-7, L.1211-8, L.1211-9)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Time of the first biopsy: H0
For the patients in arm H0, the first biopsy is done as soon as the patient is lying on the air mattress.
|
|
|
Active Comparator: Time of the first biopsy: H1
For a patient in arm H1, it is done after 1 hour lying on the air mattress.
|
|
|
Active Comparator: Time of the first biopsy: H2
For a patient in arm H2, it is done after 2 hour lying on the air mattress.
|
|
|
Active Comparator: Time of the first biopsy: H3
For a patient in arm H3, it is done after 3 hour lying on the air mattress.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The interface pressure will be continuously assessed using a mapping device (XSensor) during 3 hours.
Time Frame: The first day of the patient admission (during the first 3 hours).
|
The first day of the patient admission (during the first 3 hours).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The microvascularization changes underneath the compressed skin and the inflammatory response of the muscle cells.
Time Frame: The first day of the patient admission (during the first 3 hours).
|
The blood flow, the oxygen saturation and the hemoglobin amount will be measured using a medical device called Oxygen To See (O2C).
The reactive oxygen species or ROS and other specific biomarkers will be used to measure and quantify the inflammatory response of muscle cells.
|
The first day of the patient admission (during the first 3 hours).
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 95022
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injury
-
Ecole Polytechnique Fédérale de LausanneRecruitingChronic Spinal Cord Injury | Spinal Cord Injury (SCI) | Spinal Cord Injury | SCI - Spinal Cord Injury | SCI | Subacute Spinal Cord InjurySwitzerland
-
Lian-Cing Yan, MSPTNot yet recruitingSpinal Cord Injury | Spinal Cord Stimulation | Spinal Cord Injury/Damage | Spinal Cord Injury Thoracic | Spinal Cord Stimulation (SCS) | Spinal Cord Injury T1-L2 | Epidural Electrical StimulationTaiwan
-
Xuanwu Hospital, BeijingBeijing Pins Medical Co., Ltd; Beijing Xinzhida Neural Technology Co., Ltd; Hangzhou...RecruitingSpinal Cord Injury | Motor Deficits | Gait Impairment | Gait Training | Spinal Cord Injury Cervical | Spinal Cord Injuries (SCI) | Motor Impairment | Spinal Cord Injury, Chronic | Spinal Cord Injury Thoracic | Spinal Cord Injury (Quadraplegia)China
-
Taipei Veterans General Hospital, TaiwanThe Industrial Technology Research InstituteUnknownSpinal Cord Injuries | Complete Spinal Cord Injury | Incomplete Spinal Cord InjuryTaiwan
-
Chang Gung Memorial HospitalNot yet recruitingSpine Injury | Complete Spinal Cord Injury | Incomplete Spinal Cord Injury | Cord Injury, Spinal | Cord Infarction Spinal
-
University of FloridaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedSCI - Spinal Cord Injury | Incomplete Spinal Cord InjuryUnited States
-
Jill M. Wecht, Ed.D.Icahn School of Medicine at Mount SinaiRecruitingBlood Pressure | Spinal Cord Injuries | SCI - Spinal Cord Injury | Blood Pressure Disorders | Traumatic Spinal Cord Injury | Acute Spinal Cord Injury | Neuromodulation | Spinal Cord StimulationUnited States
-
NervGen PharmaTerminatedSpinal Cord Injuries | Chronic Spinal Cord Injury | Subacute Spinal Cord InjuryUnited States
-
MetroHealth Medical CenterNational Institute of Neurological Disorders and Stroke (NINDS); Case Western...RecruitingSpinal Cord Injuries | Spinal Cord Injury at C5-C7 Level | Spinal Cord Injury CervicalUnited States
-
Anne BrydenNational Institute of Neurological Disorders and Stroke (NINDS); Case Western... and other collaboratorsRecruitingSpinal Cord Injuries | Spinal Cord Injury at C5-C7 Level | Spinal Cord Injury Cervical | Spinal Cord Injury at C5-C7 Level With Complete Lesion | Spinal Cord Injury at C5-C7 Level With Incomplete LesionUnited States
Clinical Trials on Muscle biopsy
-
University Medical Center NijmegenUnknownSepsis | Mechanical VentilationNetherlands
-
Norman MangnerCompletedHeart Failure | Ischemic Myocardiopathy | Dilatative MyocardiopathyGermany
-
University Hospital, LilleCompleted
-
Delafontaine HospitalCompleted
-
Hasselt UniversityJessa HospitalCompletedCritical Illness | Cachexia | Muscle Atrophy | Muscle Loss | Muscle WastingBelgium
-
National Institute on Aging (NIA)Terminated
-
Purdue UniversityCompletedFlaccid Muscle ToneUnited States
-
University Hospital, AngersCompleted
-
Amazentis SACentre for Human Drug Research, NetherlandsCompleted